Bortezomib and vorinostat in refractory acute myelogenous leukemia and high-risk myelodysplastic syndromes: Produces stable disease but at the cost of high toxicity

E. D. Warlick; Q. Cao; J. Miller

doi:10.1038/leu.2013.61

Bortezomib and vorinostat in refractory acute myelogenous leukemia and high-risk myelodysplastic syndromes: Produces stable disease but at the cost of high toxicity

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1789-1791
Number of pages	3
Journal	Leukemia
Volume	27
Issue number	8
DOIs	https://doi.org/10.1038/leu.2013.61
State	Published - Aug 2013

Bibliographical note

Copyright:
Copyright 2013 Elsevier B.V., All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1038/leu.2013.61

Find It

Find It at U of M Libraries

Cite this

@article{050be49fa2a7436b9656e7f45f844986,

title = "Bortezomib and vorinostat in refractory acute myelogenous leukemia and high-risk myelodysplastic syndromes: Produces stable disease but at the cost of high toxicity",

author = "Warlick, {E. D.} and Q. Cao and J. Miller",

year = "2013",

month = aug,

doi = "10.1038/leu.2013.61",

language = "English (US)",

volume = "27",

pages = "1789--1791",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "8",

}

TY - JOUR

T1 - Bortezomib and vorinostat in refractory acute myelogenous leukemia and high-risk myelodysplastic syndromes

T2 - Produces stable disease but at the cost of high toxicity

AU - Warlick, E. D.

AU - Cao, Q.

AU - Miller, J.

PY - 2013/8

Y1 - 2013/8

UR - http://www.scopus.com/inward/record.url?scp=84881475996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881475996&partnerID=8YFLogxK

U2 - 10.1038/leu.2013.61

DO - 10.1038/leu.2013.61

M3 - Article

C2 - 23446311

AN - SCOPUS:84881475996

SN - 0887-6924

VL - 27

SP - 1789

EP - 1791

JO - Leukemia

JF - Leukemia

IS - 8

ER -

Bortezomib and vorinostat in refractory acute myelogenous leukemia and high-risk myelodysplastic syndromes: Produces stable disease but at the cost of high toxicity

Bibliographical note

UN SDGs

Publisher link

Find It

Other files and links

Cite this